Elaine Willmore
5PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 25, 2025
Targeting the MDM2-p53 Interaction with Siremadlin: A Promising Therapeutic Strategy for Treating TP53 Wild-Type Chronic Lymphocytic Leukemia.Erhan Aptullahoglu, Mohammed Howladar, Jonathan P Wallis
|Jul 27, 2024
RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in TP53 Wild-Type Chronic Lymphocytic Leukemia.Erhan Aptullahoglu, Sirintra Nakjang, Jonathan P Wallis
|Oct 14, 2023
Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling.Evan A Mulligan, Susan J Tudhope, Jill E Hunter
|Jul 29, 2023
SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia.Erhan Aptullahoglu, Jonathan P Wallis, Helen Marr
|Feb 11, 2023
Splicing Modulation Results in Aberrant Isoforms and Protein Products of p53 Pathway Genes and the Sensitization of B Cells to Non-Genotoxic MDM2 Inhibition.Erhan Aptullahoglu, Carmela Ciardullo, Jonathan P Wallis
Pageof 1
